Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKCOM Regulatory News (KCOM)

  • There is currently no data for KCOM

Directorate Change

17 May 2018 12:00

RNS Number : 4438O
KCOM Group PLC
17 May 2018
 

17 May 2018

 

KCOM Group PLC

Directorate change

 

KCOM Group PLC (KCOM.L) ("Company") announces today that Jane Aikman, Chief Financial Officer and Executive Director, has decided to leave the business to pursue other opportunities. Jane will remain with the Group to ensure that an orderly handover of her responsibilities takes place, including the finalisation of the year-end audit, and will continue as a Director until 30 June 2018.

 

The search process will begin immediately to find her successor.

 

Graham Holden, Chairman said:

 

"Jane has made an important contribution to the business, particularly her input into the further development and refinement of the Group strategy and clearer business segmentation. She has built strong, commercially focused teams and delivered improved overall governance and controls.

 

"I would like to thank her for her dedication and commitment to KCOM and for her support in the orderly transition of her responsibilities. On behalf of the Board, I would like to wish her all the best for the future."

 

KCOM Group will be announcing its full year results for the year ending 31 March 2018 on 5 June 2018. 

 

The Company stated in its trading update ahead of its Capital Markets Day on 1 February 2018 that the Group remains on track to deliver an overall EBITDA performance that is slightly ahead of the Board's expectation, and a revenue performance slightly behind, for the financial year ended 31 March 2018. 

 

An update on the process regarding the managed succession for Bill Halbert, the Group's Chief Executive will be provided at the full year results.

 

 

Enquiries:

FTI Consulting LLP

020 3727 1137

Edward Bridges/Matt Dixon/Jamie Ricketts/Leah Dudley

KCOM Group PLC

01482 602 595

Cathy Phillips, Investor Relations

 

 

The payments to be made to Jane after she leaves the business are set out below. There will be no other compensation paid for loss of office. Full details of the relevant payments will be included in the Directors' Remuneration Report for the relevant year. All payments are made in accordance with the Directors' Remuneration Policy which was approved by shareholders on 21 July 2017.

 

Salary and Benefits 

 

Jane will receive a lump sum payment in lieu of her notice period of 12 months in accordance with her contractual entitlement calculated as the sum of her base salary of £290,000, and the value of benefits of £18,456 and retirement benefits of £58,000. Her benefits consist of a car allowance, private medical insurance, health screening, income protection and life assurance.

 

The Company has also agreed to make a contribution to Jane's legal fees incurred in connection with her departure, in accordance with the Directors' Remuneration Policy.

 

Annual Bonus

 

The Remuneration Committee has agreed that Jane will also receive any bonus for which she is eligible under the annual bonus scheme for the year ended 31 March 2018, for which the calculations are still subject to external audit, due to her contribution to the business throughout the financial year. Further information on details of the bonus scheme, and the amount payable, will be included in the Directors' Remuneration Report.

 

Long Term Incentives

 

Jane was granted awards under the KCOM LTIP in January 2017 and July 2017. The performance periods for these awards end in January 2020 and July 2020 respectively. As a good leaver, Jane will be entitled to receive any shares that vest under the LTIP, pro-rated to 30 June 2019, in line with her 12 month notice period. The actual amount of shares will therefore be calculated on each vesting date, in so far as performance conditions are met at that time. Full details will be disclosed in the Directors' Remuneration Report in 2020 and 2021. Further details of the operation of the LTIP can be found in the Directors' Remuneration Report which will be published shortly in the Report & Accounts.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFKODNKBKDDPD
Date   Source Headline
1st Jul 201510:17 amRNSAnnual Financial Report
12th Jun 201511:47 amRNSDirector/PDMR Shareholding
5th Jun 20157:00 amRNSFinal Results
1st Jun 20152:26 pmRNSDirector Declaration
20th May 20154:02 pmRNSAppointment-Joint Financial Adviser & Joint Broker
12th May 20155:10 pmRNSDirector/PDMR Shareholding
13th Apr 20154:43 pmRNSDirector/PDMR Shareholding
7th Apr 201510:02 amRNSDirectorate Change
1st Apr 20155:38 pmRNSHolding(s) in Company
26th Mar 20153:30 pmRNSEmployee Benefit Trust Dealing
26th Mar 20157:00 amRNSPre-close Statement
16th Mar 201510:06 amRNSDirector/PDMR Shareholding
13th Feb 201511:14 amRNSDirector/PDMR Shareholding
5th Feb 20154:01 pmRNSDirector/PDMR Shareholding
2nd Feb 20159:56 amRNSBlocklisting Interim Review
13th Jan 20159:32 amRNSDirector/PDMR Shareholding
5th Jan 201510:22 amRNSDirector Appointment
15th Dec 20148:56 amRNSDirector/PDMR Shareholding
25th Nov 20147:00 amRNSHalf Yearly Report
19th Nov 201411:27 amRNSEmployee Benefit Trust Dealing
12th Nov 20141:26 pmRNSDirector/PDMR Shareholding
13th Oct 20144:45 pmRNSDirector/PDMR Shareholding
30th Sep 20147:00 amRNSPre-close Statement
11th Sep 20143:55 pmRNSDirector/PDMR Shareholding
11th Aug 20145:08 pmRNSDirector/PDMR Shareholding
7th Aug 20144:07 pmRNSDirector/PDMR Shareholding
1st Aug 20149:03 amRNSBlocklisting Interim Review
31st Jul 20142:42 pmRNSDirector/PDMR Shareholding
31st Jul 20142:41 pmRNSDirector/PDMR Shareholding
29th Jul 20143:03 pmRNSDirector/PDMR Shareholding
29th Jul 20142:01 pmRNSResult of AGM
29th Jul 201412:37 pmRNSRetirement of Director
29th Jul 20147:00 amRNSInterim Management Statement
18th Jul 201411:38 amRNSDirector/PDMR Shareholding
16th Jul 20144:47 pmRNSEmployee Benefit Trust Dealing
14th Jul 20142:01 pmRNSDirector/PDMR Shareholding
10th Jul 20144:33 pmRNSAnnual Financial Report
16th Jun 20145:13 pmRNSEmployee Benefit Trust Dealing
13th Jun 201412:07 pmRNSDirector/PDMR Shareholding
6th Jun 20147:00 amRNSFinal Results
14th May 20147:00 amRNSDirector/PDMR Shareholding
14th Apr 20149:59 amRNSDirector/PDMR Shareholding
25th Mar 20147:00 amRNSPre-close statement
17th Mar 201411:57 amRNSHolding(s) in Company
12th Mar 20144:36 pmRNSDirector/PDMR Shareholding
12th Feb 20149:56 amRNSDirector/PDMR Shareholding
10th Feb 20143:56 pmRNSDirector/PDMR Shareholding
5th Feb 20149:35 amRNSDirector Declaration
3rd Feb 20147:00 amRNSBlocklisting Interim Review
31st Jan 20143:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.